02315 BIOCYTOGEN-B
Trading Add to Porfolio| Index Constituent : None | |||
| Major Shareholders | Shen Yuelei (24.01%) SDIC Venture Capital Management Co., Ltd. (16.32%) [03968] China Merchants Bank Company Limited (15.62%) He Chengming & Associates (6.89%) [02628] China Life Insurance Company Limited (5.26%) |
Sector | Health Care & Biotechnology |
|---|---|---|---|
| Web Site | http://www.biocytogen.com.cn/ | Tel | (86 10) 5696-7601 |
| ir@bbctg.com.cn | Fax | (86 10) 5696-7666 | |
| Related Equities | N/A | ||
| Principal Activities | Principally engaged in providing gene editing services, pre-clinical pharmacology and efficacy evaluation services, animal models selling, antibody development and innovative biologic drug research and development. | ||
Consolidated List of Substantial Shareholders
| Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
| Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
|---|
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
